Bill Text: FL S1010 | 2022 | Regular Session | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Uterine Fibroid Research and Education
Spectrum: Slight Partisan Bill (? 2-1)
Status: (Introduced - Dead) 2022-03-04 - Laid on Table, refer to CS/CS/CS/HB 543 [S1010 Detail]
Download: Florida-2022-S1010-Introduced.html
Bill Title: Uterine Fibroid Research and Education
Spectrum: Slight Partisan Bill (? 2-1)
Status: (Introduced - Dead) 2022-03-04 - Laid on Table, refer to CS/CS/CS/HB 543 [S1010 Detail]
Download: Florida-2022-S1010-Introduced.html
Florida Senate - 2022 SB 1010 By Senator Gibson 6-01094-22 20221010__ 1 A bill to be entitled 2 An act relating to uterine fibroid research and 3 education; creating s. 381.9312, F.S.; providing 4 definitions; requiring the Department of Health to 5 develop and maintain an electronic database of 6 information related to uterine fibroids; providing a 7 specified purpose for such database; requiring that 8 the database include specified information; requiring 9 health care providers to submit certain information to 10 the department for inclusion in the database; 11 prohibiting the database from including any personal 12 identifying information; providing that such 13 information is confidential; authorizing certain 14 persons to use such information for a specified 15 purpose; requiring the department, in consultation 16 with the Florida Medical Association, to develop and 17 disseminate certain information to educate health care 18 providers and conduct a public awareness campaign; 19 providing an effective date. 20 21 Be It Enacted by the Legislature of the State of Florida: 22 23 Section 1. Section 381.9312, Florida Statutes, is created 24 to read: 25 381.9312 Uterine fibroid research database; education and 26 public awareness.— 27 (1) DEFINITIONS.—As used in this section, the term: 28 (a) “Department” means the Department of Health. 29 (b) “Health care provider” means a physician licensed under 30 chapter 458 or an advanced practice registered nurse registered 31 under s. 464.0123. 32 (c) “Uterine fibroid” means a noncancerous growth of the 33 uterus that often appears during a woman’s childbearing years. 34 (2) UTERINE FIBROID RESEARCH DATABASE.— 35 (a) The department shall develop and maintain an electronic 36 database consisting of information related to uterine fibroids. 37 The purpose of the database is to encourage research relating to 38 the diagnosis and treatment of uterine fibroids and ensure that 39 women are provided with the relevant information and health care 40 necessary to prevent and treat uterine fibroids. The database 41 must include, but need not be limited to, all of the following 42 information: 43 1. Incidence and prevalence of women diagnosed with uterine 44 fibroids in the state. 45 2. Demographic attributes of women diagnosed with uterine 46 fibroids in the state. 47 3. Treatments and procedures for uterine fibroids used by 48 health care providers in the state. 49 (b) A health care provider who diagnoses or treats a woman 50 with uterine fibroids shall submit information relating to such 51 diagnosis or treatment to the department in a form and manner 52 prescribed by department rule for inclusion in the database. 53 Such information may be submitted along with any reports or 54 other information that the health care provider is required to 55 submit to the department pursuant to state law. 56 (c) The database may not include any personal identifying 57 information of women diagnosed with or treated for uterine 58 fibroids. Such information is confidential and may be used only 59 by employees or agents of the department for the purpose of 60 conducting uterine fibroid research. 61 (3) UTERINE FIBROID EDUCATION OUTREACH AND PUBLIC 62 AWARENESS.—The department, in consultation with the Florida 63 Medical Association, shall develop and disseminate information 64 related to uterine fibroids to educate health care providers and 65 conduct a campaign to increase public awareness of uterine 66 fibroids which must include, but need not be limited to, all of 67 the following: 68 (a) Possible risk factors for developing uterine fibroids, 69 including, but not limited to, the races or ethnicities of women 70 who have a statistically elevated risk of developing uterine 71 fibroids. 72 (b) Range of available treatment options for uterine 73 fibroids, including, but not limited to, treatments and 74 procedures that are considered alternatives to hysterectomy. 75 Section 2. This act shall take effect July 1, 2022.